PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 139 filers reported holding PRECIGEN INC in Q3 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $59,177 | +19.3% | 41,674 | -3.4% | 0.00% | – |
| Q2 2023 | $49,610 | +10.7% | 43,139 | +2.0% | 0.00% | – |
| Q1 2023 | $44,826 | -6.6% | 42,289 | +33.9% | 0.00% | – |
| Q4 2022 | $47,988 | -30.5% | 31,571 | -3.1% | 0.00% | – |
| Q3 2022 | $69,000 | +56.8% | 32,571 | 0.0% | 0.00% | – |
| Q2 2022 | $44,000 | -37.1% | 32,571 | -1.4% | 0.00% | – |
| Q1 2022 | $70,000 | -43.5% | 33,044 | -1.5% | 0.00% | – |
| Q4 2021 | $124,000 | -33.7% | 33,544 | -10.3% | 0.00% | – |
| Q3 2021 | $187,000 | -36.6% | 37,394 | -17.3% | 0.00% | – |
| Q2 2021 | $295,000 | -4.8% | 45,194 | +0.6% | 0.00% | – |
| Q1 2021 | $310,000 | -39.0% | 44,944 | -9.8% | 0.00% | -100.0% |
| Q4 2020 | $508,000 | +262.9% | 49,805 | +24.3% | 0.00% | – |
| Q3 2020 | $140,000 | -24.3% | 40,057 | +7.9% | 0.00% | – |
| Q2 2020 | $185,000 | +59.5% | 37,129 | +8.5% | 0.00% | – |
| Q1 2020 | $116,000 | – | 34,217 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |